$SPRB
Spruce Biosciences, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$40.53
▲+2.23%+$0.885
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateSpruce Biosciences, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is SPRB up today? It is at $40.53 (+2.23%), and our scanner flagged it 25 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment SPRB spikes, and full due diligence on SPRB — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $SPRB 25 times in the last 30 days. Create a free account to track $SPRB, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on SPRB from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for SPRB today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystSPRUCE BIOSCIENCES, INC.: Q2 FY2026 results, three months to Jun 30, 2026, from an SEC filing. Read it →Latest filingSC 13GPassive 5%+ stake disclosedAug 14, 2026 · 65 days agoAcross every filing on file, supply equal to 179.1% of the tradeable float is in play - 179.1% has already been sold.
One filing exceeds the whole float, which usually means our share count is stale. Check the filing directly.
Recent priced share offering — a one-time sale that has already completed (not ongoing)
1,150,000 new shares
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Szwarcberg Javier B. Officer | Acquired (grant/award) | +266 | added 1.4% | 19K | $1K at $4.53 | Jun 30, 26 |
Szwarcberg Javier B. Officer | Acquired (grant/award) | +5K 0.2% of company | added 33% | 19K | $21K at $4.53 | Dec 31, 25 |
Szwarcberg Javier B. Officer | Sold (automatic/other) | -1K 0.05% of company | sold 9.0% | 14K | $110K at $80.67 | Dec 15, 25 |
Szwarcberg Javier B. Officer | Other | 3K 0.09% of company | added 22% | 15K | n/a | Dec 15, 25 |
Gharib Samir M. Officer | Sold (automatic/other) | -362 0.01% of company | sold 4.4% | 8K | $29K at $80.67 | Dec 15, 25 |
Gharib Samir M. Officer | Other | 1K 0.04% of company | added 14% | 8K | n/a | Dec 15, 25 |
Szwarcberg Javier B. Officer | Sold (automatic/other) | -2K 0.08% of company | sold 14% | 13K | $194K at $88.41 | Dec 11, 25 |
Szwarcberg Javier B. Officer | Other | 5K 0.2% of company | added 48% | 15K | n/a | Dec 11, 25 |
Gharib Samir M. Officer | Sold (automatic/other) | -680 0.02% of company | sold 8.2% | 8K | $60K at $88.41 | Dec 11, 25 |
Gharib Samir M. Officer | Other | 2K 0.07% of company | added 30% | 8K | n/a | Dec 11, 25 |
Ways Douglas Kirk Officer | Other | 1K 0.04% of company | n/a | 1K | n/a | Dec 11, 25 |
Szwarcberg Javier B. Officer | Sold (automatic/other) | -428 0.01% of company | sold 4.0% | 10K | $37K at $85.67 | Dec 10, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on SPRB from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for SPRB today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
SPRB last traded at $40.53, up 2.23% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Spruce Biosciences, Inc. Common Stock (SPRB) is next expected to report earnings on Monday, November 9, 2026, about 21 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The SPRB Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged SPRB 25 times in the last 30 days.
SPRB (Spruce Biosciences, Inc. Common Stock) trades on XNAS, with a market cap of about $114M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge SPRB for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$SPRB discussion
Sign in to ask a question or join the discussion.